Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Teligent Inc (TLGT)

Teligent Inc (TLGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 16,104
  • Shares Outstanding, K 92,817
  • Annual Sales, $ 45,310 K
  • Annual Income, $ -122,020 K
  • 60-Month Beta 1.61
  • Price/Sales 0.41
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade TLGT with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.78
  • Most Recent Earnings N/A on 08/16/21
  • Latest Earnings Date 10/03/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1650 +5.15%
on 10/15/21
0.4275 -59.42%
on 09/30/21
-0.2180 (-55.68%)
since 09/15/21
3-Month
0.1650 +5.15%
on 10/15/21
0.6300 -72.46%
on 08/04/21
-0.3265 (-65.30%)
since 07/15/21
52-Week
0.1650 +5.15%
on 10/15/21
1.6000 -89.16%
on 02/10/21
-0.5265 (-75.21%)
since 10/15/20

Most Recent Stories

More News
Teligent to Pursue Asset Sale through Voluntary Chapter 11 Process

/PRNewswire/ -- Teligent, Inc. (Nasdaq: TLGT), a New Jersey-based specialty generic pharmaceutical company ("Teligent" or the "Company"), today announced that...

TLGT : 0.1735 (-13.85%)
Teligent, Inc. Announces Second Quarter 2021 Earnings Report and Provides Business Update

TLGT : 0.1735 (-13.85%)
Teligent, Inc. to Hold Conference Call for Second Quarter 2021 Financial Results on Monday, August 16, 2021

BUENA, N.J., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT), ("Teligent" or the "Company"), a New Jersey based generics pharmaceutical company, today announced they will hold a conference...

TLGT : 0.1735 (-13.85%)
Teligent, Inc. Announces Adjournment of Annual Meeting of Stockholders

Scheduled to Reconvene on July 21, 2021 Company Urgently Encourages Stockholders to Vote

TLGT : 0.1735 (-13.85%)
Teligent, Inc. Announces Adjournment of Annual Meeting of Stockholders

Scheduled to Reconvene on June 30, 2021 Company Urgently Encourages Stockholders to Vote

TLGT : 0.1735 (-13.85%)
Teligent, Inc. Announces First Quarter 2021 Earnings Report and Provides Business Update

BUENA, N.J., May 25, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based generics pharmaceutical company, today announced its financial results for the first quarter of 2021...

TLGT : 0.1735 (-13.85%)
Teligent, Inc. to Hold Conference Call for First Quarter 2021 Financial Results on Tuesday May 25, 2020

BUENA, N.J., May 21, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT), ("Teligent" or the "Company"), a New Jersey based generics pharmaceutical company, today announced they will hold a conference...

TLGT : 0.1735 (-13.85%)
Teligent, Inc. Announces 2020 Year-End Earnings Report and Provides Business Update

BUENA, N.J., May 03, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based generics pharmaceutical company, today announced its financial results for the fourth quarter and year...

TLGT : 0.1735 (-13.85%)
Teligent Announces Hiring of Chief Financial Officer

BUENA, N.J., April 15, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, today announced the...

TLGT : 0.1735 (-13.85%)
Teligent Regains Compliance with Nasdaq Filing Requirements and Nasdaq Minimum Market Value Rule

BUENA, N.J., Jan. 22, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, previously received...

TLGT : 0.1735 (-13.85%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories,...

See More

Key Turning Points

3rd Resistance Point 0.2440
2nd Resistance Point 0.2265
1st Resistance Point 0.2000
Last Price 0.1735
1st Support Level 0.1560
2nd Support Level 0.1385
3rd Support Level 0.1120

See More

52-Week High 1.6000
Fibonacci 61.8% 1.0518
Fibonacci 50% 0.8825
Fibonacci 38.2% 0.7132
Last Price 0.1735
52-Week Low 0.1650

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar